WORLD’S FIRST SPECIES-SPECIFIC MULTI-OMICS AI DISCOVERY PLATFORM
⚡ Precision Animal Health

Revolutionizing Animal Health with AI-Powered Precision Therapeutics

SymmunoAI™, our proprietary AI platform, translates biological complexity across poultry, shrimp and finfish into functional therapeutics that solve real-world production challenges.

View Programs
Explore Platform
2.68M+Molecules Screened
186+Biological Targets
11Active Programs
3Species Platforms

PEPTOPROBE™2.68M molecules screened
SPECIES AIPoultry • Shrimp • Finfish
TARGET ENGINE186+ biological targets
EXPERIMENTAL LEARNINGIn vitro • in vivo • feedback

PEPTOPROBE™

Molecular Design Engine

AI-powered discovery and prioritization of antimicrobial peptides and other functional bioactive molecules.

SYMMUNOAI™

Biological Decision Engine

Connects pathogen biology, host response, target selection, modality choice and experimental evidence into one discovery system.

One connected discovery loop

Discover → Design → Validate → Learn

How SymmunoAI™ converts biological complexity into actionable product candidates.

01

Understand Disease

Pathogen, host, immune response and biological context.

02

Prioritize Targets

Rank high-value biological targets and intervention points.

03

Choose Modality

Vaccine, peptide, RNA, decoy or functional therapeutic.

04

Design Candidates

PeptoProbe™ and AI models create and optimize leads.

05

Validate

In vitro and in vivo testing checks efficacy and safety.

06

Learn & Advance

Experimental data feeds back into the next design cycle.

Why SymmunoAI™ is different

Built for the biology of animal health — not generic drug discovery.

1
Vertical intelligencePurpose-built for poultry, shrimp, finfish and animal-health biology.
2
Multi-modality thinkingCan select among vaccines, peptides, RNA, decoys and other interventions.
3
Experimental feedbackReal biological validation strengthens future prediction and ranking.
4
Asset creationThe goal is not software access — it is differentiated functional therapeutic for field application.

Pathogen IntelligenceGenomics, virulence, conservation, resistance and disease biology.
Host IntelligenceImmune pathways, receptors, host response and susceptibility.
PeptoProbe™Sequence discovery, activity prediction, optimization and prioritization.
Experimental IntelligenceAssay data, challenge models, efficacy, safety and biological feedback.
Knowledge LayerLiterature, omics, internal data and program memory.
Product EngineLead selection, development decisions and commercialization readiness.

POWERED BY PEPTOPROBE™

From millions of possibilities to focused product programs.

Our proprietary AI peptide discovery engine narrows a vast molecular search space into prioritized, development-ready opportunities.

Rapid discovery of novel antimicrobial peptides
High-precision screening with AI & structural models
Designed for stability, potency & safety
From sequence to validated lead — faster

◎
2.68M+
Molecules
Screened
→
⌾
186+
Targets
Analyzed
→
◇
41
Lead Candidates
Identified
→
◆
11
Programs in
Pipeline

From platform to products

Developed Functional Therapeutics

EZN101 poultry program
POULTRY

EZN101

EZ-015 shrimp program
SHRIMP

EZ-015

EpiVax shrimp vaccine
SHRIMP

EpiVax™

EzScan diagnostics
DIAGNOSTICS

EzScan™

Development portfolio

Development status by asset

Selected animal and aquatic health programs progressing from discovery through field validation.

Platform → Evidence → Asset

Asset Name Type Host Current Stage Key Milestone
EZN101 Anti-coccidiosis Poultry Field Trial Successful in vitro against 5 highly pathogenic Eimeria strains
EzScan™ WSSV Diagnostic Shrimp Field Validation Analytical validation complete, field testing underway
EZD201 Anti-coccidiosis Poultry In Vitro Potency & selectivity confirmed, PK studies underway
EZD301 Anti-coccidiosis Poultry In Vitro Potency in intestinal epithelial models, dose optimization
EZ-015 Antiviral Aquaculture In Vitro WSSV inhibition confirmed, hemocyte priming studies
EpiVax™ Epigenetic Vaccine Aquaculture Discovery In vitro transcription confirmed, hemocyte assay underway
EZS501 Anti-parasitic Aquaculture (Salmonoid) In Vitro Characterization and in vitro challenge bioassay studies

Partner with Elmentoz on co-developing and commercialization of next generation precision therapeutics for Animal and aquaculture health.

Explore Partnerships

Elmentoz is Transforming the Future of
Animal Nutrition and Therapeutics

Instagram Facebook X-twitter Linkedin-in

Quick Links

EU Office​

Drammensveien 89 B, 0271 Oslo, Norway

ralph@elmentoz.com

India (Corporate Headquarters )

107, DLF Cyber City Rd, Chandaka Industrial Estate, Patia, Bhubaneswar, Odisha 751024, India

Elmentoz Research, iSprout, 2nd floor, Sreshta Marvel, Gachibowli, Hyderabad, Telangana 500032, India

info@elmentoz.com

business@elmentoz.com

©2025 All Rights Reserved Elmentoz Research